Cargando…

Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy

Blood transferrin receptor-positive (TfR+) exosomes are a kind of optimized drug delivery vector compared with other kinds of exosomes due to their easy access and high bio-safety. Their application facilitates the translation from bench to bedside of exosome-based delivery vehicles. Methods: In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lijun, Han, Donglin, Zhan, Qi, Li, Xueping, Shan, Peipei, Hu, Yunjie, Ding, Han, Wang, Yu, Zhang, Lei, Zhang, Yuan, Xue, Sheng, Zhao, Jin, Hou, Xin, Wang, Yin, Li, Peifeng, Yuan, Xubo, Qi, Hongzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831460/
https://www.ncbi.nlm.nih.gov/pubmed/31695794
http://dx.doi.org/10.7150/thno.37220
_version_ 1783465974794551296
author Yang, Lijun
Han, Donglin
Zhan, Qi
Li, Xueping
Shan, Peipei
Hu, Yunjie
Ding, Han
Wang, Yu
Zhang, Lei
Zhang, Yuan
Xue, Sheng
Zhao, Jin
Hou, Xin
Wang, Yin
Li, Peifeng
Yuan, Xubo
Qi, Hongzhao
author_facet Yang, Lijun
Han, Donglin
Zhan, Qi
Li, Xueping
Shan, Peipei
Hu, Yunjie
Ding, Han
Wang, Yu
Zhang, Lei
Zhang, Yuan
Xue, Sheng
Zhao, Jin
Hou, Xin
Wang, Yin
Li, Peifeng
Yuan, Xubo
Qi, Hongzhao
author_sort Yang, Lijun
collection PubMed
description Blood transferrin receptor-positive (TfR+) exosomes are a kind of optimized drug delivery vector compared with other kinds of exosomes due to their easy access and high bio-safety. Their application facilitates the translation from bench to bedside of exosome-based delivery vehicles. Methods: In this study, a pH-responsive superparamagnetic nanoparticles cluster (denoted as SMNC)-based method was developed for the precise and mild separation of blood TfR+ exosomes. Briefly, multiple superparamagnetic nanoparticles (SPMNs) labeled with transferrins (Tfs) could precisely bind to blood TfR+ exosomes to form an exosome-based cluster due to the specific recognition of TfR by Tf. They could realize the precise magnetic separation of blood TfR+ exosomes. More importantly, the pH-responsive dissociation characteristic of Tf and TfR led to the mild collapse of clusters to obtain pure blood TfR+ exosomes. Results: Blood TfR+ exosomes with high purity and in their original state were successfully obtained through the pH-responsive SMNC-based method. These can load Doxorubicin (DOX) with a loading capacity of ~10% and dramatically increase the tumor accumulation of DOX in tumor-bearing mice because of their innate passive-targeting ability. In addition, blood TfR+ exosomes changed the biodistribution of DOX leading to the reduction of side effects. Compared with free DOX, DOX-loaded blood TfR+ exosomes showed much better tumor inhibition effects on tumor-bearing mice. Conclusion: Taking advantage of the pH-responsive binding and disaggregation characteristics of Tf and TfR, the SMNC-based method can precisely separate blood TfR+ exosomes with high purity and in their original state. The resulting blood TfR+ exosomes showed excellent bio-safety and enable the efficient delivery of chemotherapeutics to tumors, facilitating the clinical translation of exosome-based drug delivery systems.
format Online
Article
Text
id pubmed-6831460
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-68314602019-11-06 Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy Yang, Lijun Han, Donglin Zhan, Qi Li, Xueping Shan, Peipei Hu, Yunjie Ding, Han Wang, Yu Zhang, Lei Zhang, Yuan Xue, Sheng Zhao, Jin Hou, Xin Wang, Yin Li, Peifeng Yuan, Xubo Qi, Hongzhao Theranostics Research Paper Blood transferrin receptor-positive (TfR+) exosomes are a kind of optimized drug delivery vector compared with other kinds of exosomes due to their easy access and high bio-safety. Their application facilitates the translation from bench to bedside of exosome-based delivery vehicles. Methods: In this study, a pH-responsive superparamagnetic nanoparticles cluster (denoted as SMNC)-based method was developed for the precise and mild separation of blood TfR+ exosomes. Briefly, multiple superparamagnetic nanoparticles (SPMNs) labeled with transferrins (Tfs) could precisely bind to blood TfR+ exosomes to form an exosome-based cluster due to the specific recognition of TfR by Tf. They could realize the precise magnetic separation of blood TfR+ exosomes. More importantly, the pH-responsive dissociation characteristic of Tf and TfR led to the mild collapse of clusters to obtain pure blood TfR+ exosomes. Results: Blood TfR+ exosomes with high purity and in their original state were successfully obtained through the pH-responsive SMNC-based method. These can load Doxorubicin (DOX) with a loading capacity of ~10% and dramatically increase the tumor accumulation of DOX in tumor-bearing mice because of their innate passive-targeting ability. In addition, blood TfR+ exosomes changed the biodistribution of DOX leading to the reduction of side effects. Compared with free DOX, DOX-loaded blood TfR+ exosomes showed much better tumor inhibition effects on tumor-bearing mice. Conclusion: Taking advantage of the pH-responsive binding and disaggregation characteristics of Tf and TfR, the SMNC-based method can precisely separate blood TfR+ exosomes with high purity and in their original state. The resulting blood TfR+ exosomes showed excellent bio-safety and enable the efficient delivery of chemotherapeutics to tumors, facilitating the clinical translation of exosome-based drug delivery systems. Ivyspring International Publisher 2019-10-14 /pmc/articles/PMC6831460/ /pubmed/31695794 http://dx.doi.org/10.7150/thno.37220 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Yang, Lijun
Han, Donglin
Zhan, Qi
Li, Xueping
Shan, Peipei
Hu, Yunjie
Ding, Han
Wang, Yu
Zhang, Lei
Zhang, Yuan
Xue, Sheng
Zhao, Jin
Hou, Xin
Wang, Yin
Li, Peifeng
Yuan, Xubo
Qi, Hongzhao
Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy
title Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy
title_full Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy
title_fullStr Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy
title_full_unstemmed Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy
title_short Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy
title_sort blood tfr+ exosomes separated by a ph-responsive method deliver chemotherapeutics for tumor therapy
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831460/
https://www.ncbi.nlm.nih.gov/pubmed/31695794
http://dx.doi.org/10.7150/thno.37220
work_keys_str_mv AT yanglijun bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT handonglin bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT zhanqi bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT lixueping bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT shanpeipei bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT huyunjie bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT dinghan bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT wangyu bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT zhanglei bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT zhangyuan bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT xuesheng bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT zhaojin bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT houxin bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT wangyin bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT lipeifeng bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT yuanxubo bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy
AT qihongzhao bloodtfrexosomesseparatedbyaphresponsivemethoddeliverchemotherapeuticsfortumortherapy